🔎 Trials Near Me

Hem › Neuroblastom › Michigan

Kliniska studier för Neuroblastom i Michigan

8 studier för Neuroblastom söker deltagare vid platser i Michigan.

Städer i Michigan

Officiell studietext (engelska)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • C S Mott Children's Hospital, Ann Arbor
  • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
  • Bronson Methodist Hospital, Kalamazoo
  • och 1 fler
RekryterarFas 3
Upp till ålder 30 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06172296

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  • Corewell Health ( Site 1001), Grand Rapids
RekryterarFas 1/2
6 Months – 25 Years · Alla kön · Uppdaterad 17 sep. 2026 · NCT06395103

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

  • Helen DeVos Children's Hospital, Grand Rapids
RekryterarFas 2
Upp till ålder 22 · Alla kön · Uppdaterad 4 sep. 2026 · NCT02559778

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  • Children's Hospital of Michigan/Wayne State University, Detroit
RekryterarFas 1/2
Upp till ålder 30 · Alla kön · Uppdaterad 3 sep. 2026 · NCT06541262

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • C S Mott Children's Hospital, Ann Arbor
  • Children's Hospital of Michigan, Detroit
  • Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
  • och 2 fler
RekryterarFas 3
365 Days – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • C S Mott Children's Hospital, Ann Arbor
RekryterarFas 1/2
12 Months – 30 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT04851119

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

  • C.S Mott Children's Hospital, Ann Arbor
RekryterarFas 2
Ålder 1 till 31 · Alla kön · Uppdaterad 20 juli 2026 · NCT06450041

Neuroblastoma Biology Study

  • C.S Mott Children's Hospital, Ann Arbor
RekryterarObservationsstudie
31 Days – 99 Years · Alla kön · Uppdaterad 23 mars 2026 · NCT01587300

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.